Literature DB >> 15327998

Signals through gp130 upregulate Wnt5a and contribute to cell adhesion in cardiac myocytes.

Yasushi Fujio1, Takahisa Matsuda, Yuichi Oshima, Makiko Maeda, Tomomi Mohri, Takashi Ito, Tomoka Takatani, Mayo Hirata, Yoshikazu Nakaoka, Ryusuke Kimura, Tadamitsu Kishimoto, Junichi Azuma.   

Abstract

Glycoprotein 130 (gp130), a common receptor of IL-6 family cytokines, plays critical roles in cardiac functions. Here, we demonstrate that the stimulation of gp130 with leukemia inhibitory factor (LIF) promoted cell adhesion in a cadherin-dependent manner in cultured cardiomyocytes. Wnt5a was upregulated by the stimulation of gp130 with IL-6 family cytokines, accompanied by N-cadherin protein upregulation. Wnt5a was not induced by LIF in cardiomyocytes expressing dominant-negative STAT3. Ablation of Wnt5a by antisense cDNA inhibited LIF-induced cell adhesion. Collectively, signals through gp130 upregulate Wnt5a through STAT3, promoting the N-cadherin-mediated cell adhesion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15327998     DOI: 10.1016/j.febslet.2004.07.082

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  21 in total

1.  Chronic treatment of mice with leukemia inhibitory factor does not cause adverse cardiac remodeling but improves heart function.

Authors:  Carlos Zgheib; Fouad Anthony Zouein; Mazen Kurdi; George Warren Booz
Journal:  Eur Cytokine Netw       Date:  2012 Oct-Dec       Impact factor: 2.737

2.  SH2B1β interacts with STAT3 and enhances fibroblast growth factor 1-induced gene expression during neuronal differentiation.

Authors:  Yu-Jung Chang; Kuan-Wei Chen; Ching-Jen Chen; Ming-Hsing Lin; Yuh-Ju Sun; Jia-Lin Lee; Ing-Ming Chiu; Linyi Chen
Journal:  Mol Cell Biol       Date:  2014-01-06       Impact factor: 4.272

3.  STAT3 upregulates the protein expression and transcriptional activity of β-catenin in breast cancer.

Authors:  Hanan Armanious; Pascal Gelebart; John Mackey; Yupo Ma; Raymond Lai
Journal:  Int J Clin Exp Pathol       Date:  2010-07-25

4.  Transcriptional profiling of intrinsic PNS factors in the postnatal mouse.

Authors:  Robin P Smith; Jessica K Lerch-Haner; Jose R Pardinas; William J Buchser; John L Bixby; Vance P Lemmon
Journal:  Mol Cell Neurosci       Date:  2010-08-07       Impact factor: 4.314

5.  Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells.

Authors:  Ping Li; David Harris; Zhiming Liu; Jie Liu; Michael Keating; Zeev Estrov
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

Review 6.  Role of the Wnt-Frizzled system in cardiac pathophysiology: a rapidly developing, poorly understood area with enormous potential.

Authors:  Kristin Dawson; Mona Aflaki; Stanley Nattel
Journal:  J Physiol       Date:  2012-12-03       Impact factor: 5.182

7.  Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.

Authors:  Anthony L Schwartz; Ramiro Malgor; Eric Dickerson; Ashani T Weeraratna; Andrzej Slominski; Jacobo Wortsman; Norikazu Harii; Aimee D Kohn; Randall T Moon; Frank L Schwartz; Douglas J Goetz; Leonard D Kohn; Kelly D McCall
Journal:  Clin Cancer Res       Date:  2009-05-26       Impact factor: 12.531

Review 8.  Wnt5a: a player in the pathogenesis of atherosclerosis and other inflammatory disorders.

Authors:  Pooja M Bhatt; Ramiro Malgor
Journal:  Atherosclerosis       Date:  2014-09-03       Impact factor: 5.162

Review 9.  Macrophage Polarization and Bone Formation: A review.

Authors:  Nicole J Horwood
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

Review 10.  Vascular dysfunction as a potential culprit of sarcopenia.

Authors:  Yun Kyung Jeon; Myung Jun Shin; Sunil Kumar Saini; Carlo Custodero; Monica Aggarwal; Stephen D Anton; Christiaan Leeuwenburgh; Robert T Mankowski
Journal:  Exp Gerontol       Date:  2020-12-26       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.